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Precise control of self-renewal and differentiation of progenitor cells into the cranial neural 
crest (CNC) pool ensures proper head development, guided by signaling pathways such as 
BMPs, FGFs, Shh and Notch.  Here, we show that murine Sox2 plays an essential role in 
controlling progenitor cell behavior during craniofacial development. A “Conditional by 
Inversion” Sox2 allele (Sox2COIN) has been employed to generate an epiblast ablation of 
Sox2 function (Sox2EpINV). Sox2EpINV/+(H) haploinsufficient and conditional (Sox2EpINV/mosaic) 
mutant embryos proceed beyond gastrulation and die around E11. These mutant embryos 
exhibit severe anterior malformations, with hydrocephaly and frontonasal truncations, which 
could be attributed to the deregulation of CNC progenitor cells during their epithelial to 
mesenchymal transition. This irregularity results in an exacerbated and aberrant migration of 
Sox10+ NCC in the branchial arches and frontonasal process of the Sox2 mutant embryos. 
These results suggest a novel role for Sox2 as a regulator of the epithelial to mesenchymal 





The head develops from anteriorly located cells of the epiblast. These cells form the 
neuroectoderm that gives rise to the brain and craniofacial structures stemming via epithelial 
to mesenchymal transitions (EMT). Balanced control between self-renewal of neural 
progenitors and their differentiation into cranial neural crest cells (NCCs) ensures proper 
head development. Cranial NCCs (CNCCs) arise from a NCC pool derived from the neural 
ectoderm, and give rise to most of the peripheral nervous system and craniofacial structures. 
NCCs are induced by interactions between the neuroectoderm and adjacent non-neural 
ectoderm (Dickinson et al., 1995;Selleck and Bronner-Fraser, 1995). These interactions are 
orchestrated by a combination of signaling molecules such as Wnt proteins, bone 
morphogenetic proteins (BMPs) (Liem et al., 1995), fibroblast growth factors (FGFs), retinoic 
acid and proteins of the Notch pathway  (LaBonne and Bronner-Fraser, 1998;Aybar et al., 
2002;Aybar and Mayor, 2002;Christiansen et al., 2002;Endo et al., 2002;Garcia-Castro et al., 
2002;Villanueva et al., 2002;Wu et al., 2003). NCCs delaminate from the dorsal neural tube, 
migrate along defined territories of the craniofacial complex and finally differentiate into many 
cell types, including neurons, glial cells, Schwann cells, melanocytes, and cells of the 
connective tissue (Ayer-Le Lievre and Le Douarin, 1982).  
 
Neural crest (NC) development depends on the activation of NCC-specific genes at the 
neural plate border (Gammill and Bronner-Fraser, 2003;Heeg-Truesdell and LaBonne, 
2004;Huang and Saint-Jeannet, 2004). A number of these genes belong to the Sox (Sry 
HMG-box) family of transcription factors (subdivided into A-H groups) harboring an HMG-box 
as a DNA binding domain (Pevny and Lovell-Badge, 1997;Wegner, 1999;Wilson and 
Koopman, 2002;Bernard and Harley, 2010;Kamachi et al., 2013;Karnavas et al., 2013). 
Whereas all SoxE genes show expression in NCC progenitors at some point following NC 
induction, differences exist in the onset and sequence of events. Induction of NCC formation 
is triggered by the expression of SoxE genes (Gammill and Bronner-Fraser, 2002), such as 
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Sox8, Sox9, and Sox10 (Bowles et al., 2000). These genes are already expressed in all 
premigratory NCCs, while later their expression becomes restricted to distinct NCC-derived 
subpopulations (Stolt et al., 2004;Betancur et al., 2011). Sox8 expression occurs before NCC 
migration from the neural tube, followed by Sox9, and shortly after Sox10 (Cheng et al., 
2000b). Sox9 expression overlaps with that of a number of NCC determinant genes, such as 
FoxD3, Bmp4, cadherin 6b, Slug, and RhoB (Liu and Jessell, 1998;Briscoe et al., 2003). 
BMP signaling drives the induction, formation, determination and migration of CNCCs (Nie et 
al., 2006). Cadherin 6b establishes the premigratory NCC domain in the neural tube 
(Taneyhill, 2008). Slug induces premigratory and migratory CNCC behavior (del Barrio and 
Nieto, 2002). Foxd3 induces the segregation of NCC from the neural tube (Kos et al., 2001). 
Rho is involved in delamination of NCC from the dorsal neural tube (Rutishauser and Jessell, 
1988;Cordero et al., 2011).  As migration starts (Nakagawa and Takeichi, 1995;Jessel and 
Weiss, 1998), Slug, RhoB, N-cadherin, and cadherin 6b are down-regulated at the trunk level 
(Akitaya and Bronner-Fraser, 1992;Monier, 1995), while FoxD3 expression persists in all 
migratory NCCs (Cheng et al., 2000b;Dottori et al., 2001). On the other hand, Sox10 persists 
only in the trunk NCC populations (Cheng et al., 2000a;Remboutsika et al., 2011b). 
 
Amongst SoxB genes (Sox1, 2, 3, 14 and 21), Sox2 has been reported to play a cell-
autonomous role in NCC development (Pan and Schultz, 2011).  Sox2 is one of the early-
activated genes in the developing neural plate (Graham et al., 2003;Wen et al., 2008;Hutton 
and Pevny, 2011), and its expression is reduced in the dorsal neural tube as NCCs 
segregate and migrate. Thereafter, Sox2 expression is upregulated in a subset of cells that 
arrived at their final destination, and gradually becomes restricted to the glial sublineages 
(Aquino et al., 2006).  Sox2 prevents terminal differentiation of Schwann cells (Wakamatsu et 
al., 2004a;Le et al., 2005) and represses the melanocyte fate (Laga et al., 2010). Ectopic 
expression of Sox2 in embryonic ectoderm and neural plate explants reveals that Sox2 is 
sufficient to inhibit NCC formation both in chick and mouse embryos (Papanayotou et al., 
2008;Remboutsika et al., 2011a). It has been postulated that Sox2 counteracts neural crest 
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development (Scherson et al., 1993;Placzek and Briscoe, 2005;Remboutsika et al., 2011b), 
as the NCC marker Slug is only expressed at regions of low Sox2 expression in premigratory 
and migratory NCCs (Wakamatsu et al., 2004b). Despite evidence that points to an 
involvement for Sox2 in multiple steps of NCC development in mouse embryo, its role is yet 
elusive 
Homozygous Sox2-null mouse embryos die around implantation (Avilion et al., 
2003b;Mandalos et al., 2012). We have developed a conditional ablation strategy, using a 
“Conditional by Inversion” Sox2 allele (Sox2COIN) (Mandalos et al., 2012), in order to study 
the role of Sox2 in epiblast-derived multipotent lineages. Here, we show that Sox2 plays an 
essential role in controlling the behavior of the progenitor cells during head development. 
EMT is affected in mutant embryos during CNCC development, resulting in hydrocephaly 
and frontonasal defects. These results suggest a novel role for Sox2 as a rheostat of the 
EMTs that influence head development in mice. 
 
Materials and Methods 
Experimental animals 
Generation of Sox2COIN mice was described elsewhere (Mandalos et al., 2012).  All animals 
were handled in strict accordance with good animal practice as defined by the Animals Act 
160/03.05.1991 applicable in Greece, revised according to the 86/609/EEC/24.11.1986 EU 
directive regarding the proper care and use of laboratory animals and in accordance to the 
Hellenic License for Animal Experimentation at the BSRC “Alexander Fleming” (Prot. No. 
767/28.02.07) issued after protocol approval by the Animal Research Committee of the 





Tail, yolk sack or embryonic tissues were isolated and processed according to previously 
described methodology (Mandalos et al., 2012). PCR amplification conditions and primers 
used are described elsewhere (Mandalos et al., 2012). 
	  
Embryo processing and histological analysis 
For staging of the embryos, midday of the vaginal plug was considered as embryonic day 0.5 
(E0.5). All embryos were harvested in cold 0.12 M phosphate-buffered saline (PBS, pH 7.5).  
For histological analysis, embryos were fixed with 10% formalin for 24 hours at room 
temperature and then washed several times with PBS, placed in embedding cassettes and 
sectioned in a Leica RM2125RT microtome. Paraffin sections (10µm) were stained with 
hematoxylin and eosin and mounted with xylene based mounting medium, according to 
standard procedures (Fischer et al., 2008;Cardiff et al., 2014) .  
 
Embryos were harvested and fixed with 4% paraformaldehyde (PFA) in PBS overnight at 4oC 
and thoroughly washed with PBS. Fixed embryos were incubated with 20% sucrose 
overnight at 4oC for cryoprotection before they were embedded with O.C.T. compound (VWR 
International), snap-frozen in dry ice and stored at -80oC. Sagittal sections were prepared 
using a Leica cryostat. Cryosections (10-12µm) were collected on Superfrost Plus 
microscope slides (VWR International) and stored at -20oC before analysis. For in situ 
hybridization, embryos were fixed overnight in PFA 4% in PBS then rinsed three times in 
PBS/Tween (0.1%) followed by three times wash in methanol before storage at -20°. 
Conventional bright field and fluorescence microscopy was performed under a Leica 
MZ16FA stereoscope. 
 
RNA in situ hybridization 
RNA probes for in situ hybridization reactions were prepared by in vitro transcription as 
previously described (Knuchel et al., 2000;Chotteau-Lelievre et al., 2006;Rhinn et al., 2011) 
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The probes used were: Hoxa2 and Hoxb1, kindly provided by Robb Krumlauf; Sox2, kindly 
provided by Robin Lovell-Badge; Sox10, kindly provided by Benoît de Crombrugghe. Whole-
mount in situ hybridization (ISH) was performed using an Intavis InSituPro robot (detailed 
protocol available at http://empress.har.mrc.ac.uk/, gene expression section).  
 
Image analysis 
Embryo dissections, conventional bright field and fluorescence microscopy were performed 
under a Leica MZ16FA stereoscope, equipped with a Leica 350 camera and Leica Software. 
Sections were photographed under a Leica M420 macroscope and DMLB/DM4000B 
microscopes equipped with Photometrics digital cameras and the CoolSnap imaging 




Epiblast deletion of Sox2 results into lethality around E11 
The epiblast is destined to derive all multipotent lineages in the mouse embryo. Previously 
generated, null alleles of Sox2 (Sox2βgeo/βgeo and Sox2βgeo2/βgeo2 ) are responsible for an early 
embryonic lethal phenotype (Avilion et al., 2003a;Ekonomou et al., 2005), masking any 
subsequent role of Sox2 in the generation of epiblast-derived multipotent lineages during 
development. Taking into account the challenges of the Sox2 locus, in that its proximal 
promoter and coding region are entirely contained within a CpG island, and are also spanned 
by an overlapping transcript, Sox2Ot, which contains mmu-miR1897 (Amaral et al., 
2009;Shahryari et al., 2013), we developed a novel conditional by inversion Sox2COIN allele 
(Mandalos et al., 2012). The inverted COIN Sox2 allele (Sox2INV) is functionally null  
(Mandalos et al., 2012), as  Sox2INV/INV mutants recapitulate the phenotype of Sox2βgeo/βgeo 
(Avilion et al., 2003a), Sox2βgeo2/βgeo2 (Ekonomou et al., 2005) and Sox2EpINV/βgeo2  (Mandalos 
et al., 2012) embryos, which die around implantation. 
 
We generated epiblast inverted Sox2EpINV/+ mice, making use of the Tg(Sox2-CRE) mouse 
line that exerts efficient Cre-mediated recombination in the epiblast, but not in 
extraembryonic tissues (Hayashi et al., 2002b;a;Hayashi et al., 2003;Vincent and Robertson, 
2003). Excision of the floxed sequences by Tg(Sox2-CRE) mice efficiently results in the 
visualization of eGFP in the epiblast at E6.5 (Figure 1A-D).  
 
As Sox2 is known to function as a cell fate determinant (Kondo and Raff, 2004;Yamaguchi et 
al., 2011;Karnavas et al., 2013), we harvested embryos from various intercrosses at the 
onset of organogenesis (E11.5). Initially, we performed Sox2EpINV/+ x Sox2+/+ intercrosses and 
found that heterozygous E11.5 Sox2EpINV/+ embryos do not show any obvious abnormalities 
and are indistinguishable from control Sox2COIN/COIN and Sox2+/+ littermates (Figure 1E-G). 
E11.5 Sox2EpINV/+ embryos express eGFP precisely in the areas where Sox2 is expressed 
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(Avilion et al., 2003a;Mandalos et al., 2012) (Figure 1H-J). Sox2EpINV/+ adult mice are fertile, 
feed normally, have normal body weight and normal lifespan, whilst Sox2INV/+ adult male 
exhibit no infertility problems, as some Sox2βgeo/+ mice reportedly have (Avilion et al., 2003b). 
It is tempting to suggest that infertility problems in Sox2βgeo2/+ and Sox2βgeo2/+ mice could arise 
from the removal of regulatory regions due to the design of the mutants, while in Sox2EpINV/+ 
mice the whole sequence of the locus remains intact after inversion (Mandalos et al., 2012). 
 
Epiblast deletion of Sox2 results into hydrocephaly and craniofacial defects 
We then proceeded to Sox2EpINV/+ intercrosses and harvested the embryos again at E11.5 
(Table I). Normally, if all Sox2EpINV/+ and Sox2EpINV/EpINV embryos would survive, one would 
expect that 75% of the embryos would be eGFP-positive (eGFP+). However, we observed 
that only 48.8% of the embryos harvested were eGFP+, suggesting that as previously 
observed (Mandalos et al., 2012), the Sox2EpINV/EpINV die in the deciduas at an early stage 
(Table I). Half of the harvested eGFP+ heterozygote embryos had normal phenotypes 
Sox2EpINV/+ (Figure 1L, P), while the remaining ones represented haploinsufficient Sox2EpINV/+ 
(Sox2EpINV/+(H)) mutants (Figure 1Q, R). The Sox2EpINV/+(H) observed embryonic phenotypes fall 
in two categories: (a) Sox2INV/+(H) embryos with a similar size to Sox2+/+ and Sox2INV/+ embryos 
(Figure 1M, Q) and (b) Sox2INV/+(H) embryos with a significantly reduced size (Figure 1N, R) 
compared to Sox2+/+ (Figure 1K, O) and Sox2EpINV/+ littermates (Figure 1L, P).  Sox2EpINV/+(H) 
embryos exhibit heart defects, hemorrhage, bulging fourth ventricular roof, and severe 
craniofacial defects (Figure 1M).  We harvested litters at E12.5 and E15.5 derived from 
Sox2EpINV/+ intercrosses and found only Sox2+/+ and Sox2EpINV/+ normal embryos, suggesting 
that Sox2EpINV/+(H) embryos die at around E11. Phenotypic differences among heterozygote 
Sox2EpINV/+ and Sox2EpINV/+(H) littermates, derived from Sox2EpINV/+ intercrosses confirm that 
there is a Sox2 expression threshold, below which phenotypic abnormalities appear during 
embryogenesis. To generate conditional epiblast-inverted Sox2 mutants, we performed 
Sox2COIN/COIN to Sox2EpINV/+; Tg(Sox2CRE) intercrosses and named these conditional mutant 
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embryos Sox2EpINV/mosaic. We could harvest Sox2EpINV/mosaic embryos from E8.5-E11.5, but not 
beyond E11.5, indicating that these mutants, similarly to Sox2EpINV/+(H) mutants, die around 
E11.5. Sox2EpINV/mosaic embryos exhibited similar, albeit more severe, abnormalities compared 
to Sox2EpINV/+(H) embryos (Figure 2B, C, E, F). 
To examine whether a regional loss of Sox2 expression was responsible for those defects, 
we analyzed Sox2 expression by RNA in situ hybridization (Figure 2D-F). Sox2 was absent 
throughout the spinal cord (sc) in E10.5 mutants, with an exception of the tail tip of both 
Sox2EpINV/+ and Sox2EpINV/mosaic mutants (Figure 2E, F). However, there were no obvious 
morphological defects in the SC at E10.5, suggesting that down-regulation of Sox2 could be 
rescued due to the functional redundancy of Sox2 with other SoxB genes, namely Sox1 and 
Sox3 (Uwanogho et al., 1995;Rex et al., 1997;Wood and Episkopou, 1999a;Archer et al., 
2011;Elkouris et al., 2011). We observed a down-regulation of Sox2 in the frontonasal 
process (fnp), the forebrain region (fb), the midbrain (mb) and the hindbrain (hb), the eye 
(Hever et al., 2006) and the otocyst (ot) (Kiernan et al., 2005;Hume et al., 2007;Pan et al., 
2013) of Sox2EpINV/+(H) and Sox2EpINV/mosaic mutant embryos. Morphologically, there was a 
distortion of the eye, an enlargement of the brain ventricles, and marked translucency in the 
hindbrain region.  
 
Several studies have shown that regulation of EMT during NCC development plays a crucial 
role for the normal development of the frontonasal region, including the palate and nasal 
cavities (Kang and Svoboda, 2005). We observed that Sox2 protein marks specific brain and 
craniofacial regions during their development (Figure 3). In E11.5 embryos, expression is 
seen in the hindbrain and forebrain neuroepithelium, and in the oral epithelium (Figure 3A-D). 
At E15.5, Sox2 is expressed in the dermis surrounding developing hair follicles and whiskers, 
including in their dermal papilla (Figure 3H-J). Sox2 is also detected in the epithelium of the 
retina (Figure 3K), in developing bone and cartilage (Figure 3L), in muscle fibers (Figure 3M 
and N) and the acinar structures of the salivary glands (Figure 3O). Furthermore, Sox2 
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asymmetrically marks the epithelium that connects the developing molar teeth with the oral 
epithelium (Figure 3P). At later post-natal stages Sox2 is expressed in the alveolar bone (ab) 
(Figure 3T) and in the incisor labial cervical loop (cl, Figure 3R and S). In the hair follicles the 
expression is confined to some cells of the inner and outer sheath (figure 3Q, U).  
 
 To further analyze the craniofacial defects observed in Sox2EpINV/+(H) embryos, we 
harvested E11.5 Sox2EpINV/+ (H) mutants and sectioned them for hematoxylin and eosin 
histological analysis (Figure 4A-D). Compared to Sox2+/+ normal embryos, we observed a 
reduction of the thickness of the neuroepithelial wall lining the telencephalic (fb), 
mesencephalic (mb) and rhombencephalic (hb) ventricles, defective frontonasal proccess 
and oral cavity formation, and dilated lumen of the optic stalk. Thus, Sox2 loss leads to 
severe brain and craniofacial defects.   
 
Sox2 loss leads to down-regulation of Hoxa2 in rhombomere 3, but not Hoxb1 in 
rhombomere 4 
In order to find out whether Sox2 loss of function disrupts the Hox code in hindbrain, we 
analyzed the expression of Hoxa2 and Hoxb1 at E8.5 in Sox2+/+ and Sox2EpINV/mosaic embryos, 
using whole mount in situ hybridization (Figure 5A, B). We observed that Hoxa2 is down-
regulated in rhombomere (r)3, but not in r5 of Sox2EpINV/mosaic mutant embryos, underscoring a 
specific role for Sox2 in the regulation of Hoxa2 in r3 at E8.5 (Figure 4A-B). To find out 
whether Sox2 loss of function affects the facial innervation programme, we analyzed the 
expression of Hoxb1 in Sox2+/+ and Sox2EpINV/mosaic embryos, and found that Hoxb1 
expression was unaffected both in r4 (Figure 4A, B) and in the spinal cord (data not shown) 
of E8.5 Sox2EpINV/mosaic embryos. Thus, our results do not support previous reports on Sox2 
involvement in the regulation of Hoxb1 in vitro, at least with regard to E8.5 hindbrain and 
spinal cord regions. As predicted from these observations, when cranial nerves were stained 
for Sox10 expression at E11.5 in mutant embryos (Figure 4C-D), we found that Sox2 loss of 
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function does not affect the formation of Sox10+ ganglia of the spinal accessory, vagus (n10), 
glossopharyngeal (n9), and branches of facial (n7) nerves (Figure 4C-D).  
 
Sox2 fine-tunes the flow of migrating Sox10+ NCCs 
To investigate the fate of NCCs that may unde to craniofacial abnormalities observed in Sox2 
mutants, we analyzed Sox10 expression in Sox2+/+ and Sox2EpINV/+(H) embryos at E9.5, at an 
embryonic stage in which Sox10+ NCCs are migrating along the lateral surface of the neural 
tube in wild-type embryos. We found that Sox10+ cells expressing high levels of Sox10 are 
heterotopically present in the frontonasal region and in the branchial arches (ba) 1-2 of 
Sox2EpINV/+(H) mutants (Figure 5A). Thus, down-regulation of Sox2 causes a dramatic up-
regulation of Sox10 expression and an outflow of Sox10+ cells in the hindbrain (hb) and 
branchial areas of mutant embryos. Furthermore, we observed Sox10+ cells in Sox2EpINV/+(H) 
mutant embryos in frontonasal areas, where Sox10 is normally not expressed, while 
migrating CNCC do not express Sox10 at this embryonic stage in Sox2+/+ control embryos 






EMT plays a crucial role in the development of the embryonic head (Mitsiadis, 2011). CNCCs 
undergo EMT and individual cells delaminate from the lateral ridges of the dorsal neural tube 
and migrate to the craniofacial area (Kouskoura et al., 2011) to form the frontonasal, 
maxillary and mandibular processes (Bronner-Fraser, 2002). Amongst genes of the SoxB1 
group (Sox1-3), which are predominantly expressed in the developing central nervous 
system (CNS) (Collignon et al., 1996;Wood and Episkopou, 1999b), Sox3 activity is required 
for pharyngeal segmentation and for the pharyngeal epithelium to proceed towards 
craniofacial morphogenesis (Rizzoti and Lovell-Badge, Development 2007). On the other 
hand, Sox2 activity has been implicated in processes that counteract NCC development 
(Hutton and Pevny, 2011;Remboutsika et al., 2011a;Cimadamore et al., 2012) and could 
affect the generation of NCC progeny, as observed in differentiation experiments of human 
ES cells (ESC)-derived neural crest cells into sensory neurons in vitro (Cimadamore et al., 
2012). Thus, the severity of defects observed in the developing brain and facial structures of 
Sox2EpINV/+(H) and Sox2EpINV/mosaic mutants underline a Sox2 dosage-dependent role in the 
development of both the head and craniofacial areas.  
 
Sox2EpINV/+(H) and Sox2EpINV/mosaic embryos suffer from ventriculomegaly, which in turn leads to 
the accumulation of increased amounts of cerebrospinal fluid (CSF) in the brain. 
Hydrocephaly involves both dilated ventricular system and increased intracranial pressure. 
Every reduction in the thickness of the ventricular wall invevitably will result in dilation of the 
ventricular system (hydrocephalus ex vacuo). It is difficult to establish cause and effect 
relationship in this reciprocal setting, however abnormal brain wall development will definitely 
lead to morphologically enlarged ventricular system. The indication that the ventricular 
system is enlarged could not in itself be considered proof of hydrocephaly, because there is 
thickness of the wall, thus pointing to ventriculomegaly only (DeVeale et al., 2013). Likewise, 
reduction in the diameter of the aqueduct and abnormal periaqueductal region development 
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does not prove etiological relationship towards hydrocephalus causation (Thomas et al, 
2012). In adult animals, hydrocephaly involves also defects in choroid plexus, but as this is in 
very early stages in development at the embryonic period we examined, the contribution of 
CSF overproduction in hydrocephalus causation is hard to assess (Mizusawa, 1997). 
Sox2EpINV/+(H) and Sox2EpINV/mosaic mutants display developmental defects both in ventricular 
system/wall formation, as well as in the oral cavity morphology that could contribute to early 
pathoanatomical events resulting in hydrocephalus and craniofacial defects in humans 
(Panetta et al., 2008). Thus, disruption of Sox2 function in the embryonic head region could 
be an additional cause for the development of hydrocephalus later on in life. 
 
Hox genes play an essential role in the development of craniofacial structures (Trainor and 
Krumlauf, 2000;Narita and Rijli, 2009;Tumpel et al., 2009;Di Bonito et al., 2013). At E8.5, 
Hoxb1 is expressed in r4 and throughout the spinal cord region (Gavalas et al., 2003), where 
it is required for the specification of facial branchiomotor neuron progenitors that are 
programmed to innervate the facial muscles (Arenkiel et al., 2004). Despite the fact that Sox2 
has been shown to regulate Hoxb1 in vitro (Di Rocco et al., 2001;Williams et al., 2004;Lian et 
al., 2010), the expression of Hoxb1 appeared to be unaffected both in r4 and in the spinal 
cord of E8.5 Sox2INV/mosaic embryos (Figure 4). Our results do not support previous reports on 
Sox2 involvement in the regulation of Hoxb1 in vitro, at least with regard to E8.5 hindbrain 
and spinal cord regions. On the other hand, Hoxa2 appears to be down-regulated in our 
mutants. At E8.5, Hoxa2 has a limit of expression in the rhombencephalic neural tube 
corresponding to r3 and r5 (Prince and Lumsden, 1994).	  It is not surprising that no effect was 
observed in Hoxa2 expression in r5, as Sox2 is expressed along the hindbrain in all 
rhombomeres, but not in r5 (Wood and Episkopou, 1999b). Hoxa2-null mutant embryos lack 
craniofacial and cartilage elements derived from the first and second branchial arch and die 
perinatally due to cleft palate (Vieille-Grosjean et al., 1997;Rijli et al., 1998;Trainor and 
Krumlauf, 2001;Santagati et al., 2005). Sox2 has been shown to interact in vitro with a SoxB 
DNA binding element (ACAAT motif) present in the enhancer of the Hoxa2 gene and 
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mutation of this motif reduces the expression of a Hoxa2 reporter in electroporation 
experiments in chick embryo hindbrains (Tumpel et al., 2008). The reduction of Hoxa2 
expression in Sox2EpINV mutants indicates that Sox2 controls an integral component of NCC 
morphogenetic program, which requires Hoxa2 at discrete time points to pattern distinct 
derivatives in craniofacial structures (Santagati et al., 2005).  
As neural progenitor cells differentiate into NCCs, a switch in expression from SoxB to SoxE 
genes becomes evident, with Sox2 inactivated in the NCC progenitors, whereas Sox9 and 
Sox10 are activated in newly migrating trunk NCCs (Melton et al., 2004;Remboutsika et al., 
2011b). This is a necessary switch for the activation of the complex mechanism that 
generates NCCs (Wakamatsu et al., 2004b). Amongst the SoxE genes, Sox10 is required for 
the formation, maintenance of multipotency, specification and differentiation of NCCs (Kelsh, 
2006). Sox10 is the only SoxE gene that maintains its expression during migration of NCCs 
along the lateral surface of the neural tube (McKeown et al., 2005), except in the cranial 
region. Sox10 mutations lead to several craniofacial abnormalities in humans, called 
neurocristopathies, including Waardenburg-Hirschsprung syndrome and peripheral 
neuropathies (Hoke, 2012). Sox2 over-expression and Sox2+ neural stem cell transplantation 
experiments in avian and murine cranial neural tubes have demonstrated that Sox2 restricts 
neuroepithelial differentiation into CNCCs (Cheung and Briscoe, 2003;Remboutsika et al., 
2011b;Wahlbuhl et al., 2012). Thus, the exacerbation of Sox10+ migrating cells in the 
Sox2EpINV mutants may not be surprising. These observations point out that Sox2 could act to 
repress Sox10 expression. However, any genetic interaction between Sox2 and Sox10 in 
neural progenitor or NCC progenitor cells is far from evident in vivo and in vitro. Whether 
Sox2 could influence the expression of Sox10 directly or indirectly by affecting levels of other 
SoxE genes such as Sox8 and Sox9 that contribute to the induction of Sox10 in NCC 
progenitors, once neural crest-inducing signals are set (Taylor and Labonne, 2005;McCauley 
and Bronner-Fraser, 2006;Haldin and LaBonne, 2010;Stolt and Wegner, 2010;Wahlbuhl et 
al., 2012), remains to be investigated. In the Sox2EpINV mutants, Sox10 levels appear 
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dramatically increased both in the branchial arches area and in the frontonasal area. Sox10 
over-expression has been shown to arrest the neuroepithelial and cranial mesenchymal cells 
in an undifferentiated state, causing a range of cell fate specification defects (Ahlstrom and 
Erickson, 2009). Neural progenitor cells, which over-express Sox10 remain undifferentiated 
and fail to form neuronal, Schwann, or melanocyte cells (Stolt et al., 2008). Thus, it is 
tempting to suggest that the failure of the embryos to form the craniofacial region could, in 
part, be due to the failure of the cranial mesenchyme to proceed through development due to 
an aberrant and exacerbated population of Sox10+ cells in the frontonasal region. 
 
In recent years, the importance of NCCs as inducers of peripheral neural structures, 
craniofacial tissues and other peripheral mesodermal-derived structures has become evident 
(Trainor and Tam, 1995;Trainor et al., 2003;Hong and Saint-Jeannet, 2005;Cordero et al., 
2011;Hagiwara et al., 2014). Defects in their development has been attributed to a failure 
and/or abnormal NCCs migration and differentiation (Bronner, 2012), resulting into the 
generation of neurocristopathies in humans (Etchevers et al., 2006) and expanding the most 
recent classification of neurocristopathies to an entire category of abnormal induction of non-
neural NCC-derived peripheral structures of the body (Cossais et al., 2010). Recent evidence 
has shown that Sox2 has been indirectly associated with defects that are characteristic of the 
CHARGE syndrome, a human neurocristopathy (Aramaki et al., 2007). CHARGE syndrome 
patients exhibited mutations in the Chd7 gene (Vallaster et al., 2012), the product of which 
acts as a Sox2 transcriptional cofactor (Engelen et al., 2011;Puc and Rosenfeld, 2011). Our 
results suggest a Sox2 dosage-dependent mechanism acting during head development, with 
a specific role for Sox2 in the prevention of these CNCC-related pathologies. We propose 
that Sox2 acts as a rheostat of EMT during CNCC development that influences cell fates 
involved in head development (Figure 7). These findings open novel avenues to target Sox2 
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Table I. Analysis of progeny from Sox2EpINV/+x Sox2EpINV/+intercrosses# 
 
 Genotypic distribution obtained at E11.5* 
 
 
Total Dead           Live      Sox2EpINV/+     Sox2EpINV/+ (H) Sox2EpINV/EpINV Sox2+/+ 
43 11(25.6%)       32(74.4%)          11(25.6%)    10 (23.2)**       0 (0%)  11(25.6%) 
 
 
#Data collected from mice in CBAxC57 (F1) background 
*Genotypes were assessed by PCR either from tail biopsies or from embryonic yolk sac or whole embryos 




Legends to Figures   
 
Figure 1. Sox2 inversion in the epiblast leads to embryonic lethality at E11.5. 
Generation of the epiblast-inverted Sox2EpINV allele. Sox2EpINV/+ embryos at E6.5 show normal 
morphology compared with Sox2+/+ control embryos. eGFP expression indicates that Sox2 is 
highly expressed in the epiblast, but not in the extraembryonic tissue (A-D). Sox2EpINV/+ 
embryos obtained from Sox2EpINV/+ x Sox2+/+ intercrosses are normal.  At E11.5, Sox2COIN/COIN 
and Sox2EpINV/+ embryos are indistinguishable from Sox2+/+ littermates (E-J). Sox2EpINV/+ 
intercrosses generate normal (Sox2EpINV/+) and haploinsufficient (Sox2EpINV/+(H)) embryos 
(M,N,Q,R). 50% of the haploinsufficient Sox2EpINV/+(H) embryos have normal size (M, Q), 
whereas the remaining ones have a smaller size (N, R) at E11.5. Both types of Sox2EpINV/+(H) 
mutant embryos show evident defects in the head region (M, N).  
Figure 2. Sox2 loss leads to multiple developmental defects. eGFP expression 
recapitulates the expression of Sox2 in Sox2EpINV/mosaic mutat (A-C). Whole mount in situ 
hybridization shows down-regulation of Sox2 in the hindbrain (hb), midbrain (mb) and 
forebrain (fb) regions, in the frontonasal process (fnp), the eye (ey), the surface ectoderm of 
branchial arches 1 and 2 (ba1, ba2), and the spinal cord (sc) but not the tail tip, of E10.5 
Sox2EpINV/+(H) and Sox2EpINV/mosaic embryos. These embryos show increased translucency 
mostly visible at the level of the hindbrain (hb); forebrain (fb) and midbrain (mb). Ventricles 
are also enlarged and frontonasal truncations are evident (D-F). 
Figure 3. Immunohistochemical analysis of Sox2 expression in developing 
craniofacial structures.   At E11.5 Sox2 is detected in hindbrain (hb) and forebrain (fb), as 
well as in the oral epithelium (oe) (A-D).  At E13.5, expression appears in the nasal 
epithelium (ne) (E-G).  At E15.5 Sox2 is expressed in the dermis surrounding the developing 
whiskers (w), and in their dermal papilla (wp) (H-P). Expression is also detected in the retina 
(r, K), in developing bone (b) and cartilage (c, L), in developing muscle fibers (mf, M, N), and 
in salivary glands (sg, O). Noteworthy, the expression of Sox2 in the developing molar teeth 
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is asymmetrical, being restricted to the connection between the tooth and the oral epithelium 
(oe) along the lingual side (P).  At postnatal day 1 (PN1), Sox2 expression is limited to some 
cells of the inner and outer root sheath of the whisker epithelium (we, the outer root sheath 
being delimited by red dots, Q) (Q-U). Sox2 is furthermore expressed in the labial cervical 
loop (cl) of the incisor (inc) (R and S), in the alveolar bone (ab) (T, S) and the vasculature 
(U).  de, dental epithelium; dm, dental mesenchyme; dp, dental papilla; fnp, frontonasal 
process; hl, hindlimb; m, mesenchyme; md, mandible; mx, maxilla; n, nose; np, nasal 
process; e, epithelium; g, glomerulae; k, keratinized part of the whisker; v, vessel; sm, 
smooth muscle; sg, salivary gland; c, cartilage; r, retina; f, follicle; mf, muscular fibers. 
 
Figure 4. Sox2INV/+(H) E11.5 embryos exhibit brain and craniofacial malformations.  
Histological analysis of Sox2+/+ and Sox2EpINV/+(H) embryos head structures (A-D). Serial 
sagittal sections of E11.5 embryos stained with hematoxylin and eosin. Sox2EpINV/+(H) 
embryos exhibit thinness of the ventricular wall and abnormal oral cavity formation enlarged 
forebrain and midbrain ventricles, while the frontonasal process (fnp) is severely reduced 
with an abnormal oral cavity (B,D) when compared Sox2+/+ littermates (A,C). 
 
Figure 5. Hoxa2 and Hoxb1 expression in rhombomeres, and Sox10 expression in 
developing cranial nerves and ganglia. In situ hybridization for Hoxa2 and Hoxb1 at E8.5 
reveals that Hoxa2 is down-regulated in rhombomere 3 of a Sox2INV/mosaic embryo, but not in 
rhombomere 5 (A, B). Hoxb1 is normally expressed in r4 in Sox2INV/mosaic mutants (A, B). 
Sox10+ nerves form normally in Sox2EpINV/+(H) embryos.  In situ hybridization reveals that 
Sox10 expression is not affected in branchial arches 1 and 2 (ba1, ba2) in developing cranial 
nerves and ganglia (n10, n9, n5mx, n5md, g7-8, g5, n5o) of Sox2EpINV/mosaic mutants 
compared with Sox2+/+ control embryos (C, D). ey, eye. 
 
Figure 6. Sox2 regulates the flow of Sox10+ NCC. NCC formation and migration is 
exacerbated in E9.5 Sox2INV/+(H) mouse embryos, as observed by the Sox10 in situ 
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hybridization pattern in branchial arches 1 and 2 (ba1, ba2), and in the frontonasal (fnp) area 
of Sox2INV/+(H) embryos when compared to Sox2+/+ embryos (A, B). Coronal sections of E9.5 
Sox2INV/+(H) and Sox2+/+ embryos. Enlargement of the fourth ventricle and the mandibular 
component of the ba1 is observed. Exacerbated numbers of Sox10+ cells are observed in 
cranial and trunk regions, in the frontonasal region and throughout ba1 (C-D). fb, forebrain; 
fnp, frontonasal process; mb, midbrain; sc, spinal cord; h, heart;  
 
Figure 7. Sox2: a rheostat of EMT transition during neural crest development. Precise 
timing ensured by an extremely accurate developmental clock regulates the dynamics of the 
decisions to generate NCC from neural progenitors. Sox2 controls the flow of the EMT 
transition, leading to NCC migration in appropriate numbers at the appropriate regions in the 
head. This way, sequence (from neural progenitor to NCC) and genetic heterochrony 
(spatially and temporally controlled Sox10 expression), resulting into craniofacial 
malformations could be averted. 
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